A New Dubai Logistic Hub is Launched by Pharma Giant Sanofi

by Zaara 23, Dec 2019

Sanofi, One of the largest facilities of its kind in the Middle East pharmaceutical industry a pharma giant which serves as the major health care solution in more than 170 countries around the world 75 industrial sites in 33 countries is going to launch its new logistics hub in Dubai. Sanofi is going to deliver over 22 million packs of medicines every year to treat patients in six countries, including the UAE, Kuwait, Bahrain, Jordan, and Iraq.

Healthcare Facilities in the UAE

The UAE was ranked with the best health care sector in the Middle East, and also faring high scores on a global scale. In the global survey, the UAE was ranked at 10th place and scored higher than Norway, Canada, and Sweden. As the population is increasing continuously, the increasing opportunities in healthcare sector are clearly evident to improvise more and more, many pharmaceutical companies are paying interest to set up their franchise in the UAE. Even the Ministry of Health is undertaking a multimillion-dollar program to expand health facilities and hospitals, medical centers, and a trauma center in seven emirates.

Sanofi, a global biopharmaceutical giant

Sanofi began operations in the Gulf in the 1970s and established its first affiliate in 1987 in the UAE. Employing over 500 people, the company offers healthcare and well-being solutions emphasized on diabetes and cardiovascular diseases, oncology, immunology, multiple sclerosis, rare diseases, and vaccines. Now the new facility increases the company’s storage capacity by 68 percent.

At 2,740 square meters, Occupying from Kuehne + Nagel, the warehouse has 4,000 pallet locations for ambient temperature control storage and a 450 pallets location for cold chain products storage.

The facility is one of the largest of its kind in the Middle East pharmaceutical industry is going to set up in Dubai. The move complements Dubai’s medical supply chain. The distribution center well equipped with the latest warehousing and cold chain technologies and also facilitates to delivery of more than 22 million packs of medicine every year for patients in six countries.

How Sanofi is going to Boost Pharma Logistics Capacities!

The huge healthcare facility was launched in the presence of Dr. Amin Hussain Al Amiri, Assistant Undersecretary for Public Health Policy and Licensing at the UAE Ministry of Health and Prevention. He said  “An efficient supply chain is fundamental to ensuring access to quality treatment for many. This is an important priority for the UAE, and we applaud Sanofi for its efforts and contribution towards the continued achievement of this goal in the country.”

Jean-Paul Scheuer, general manager of Sanofi Gulf, said that moving to the new facility has enabled the company to increase its storage capacity by 68 percent. said “Beyond expanding operationally, this investment, more importantly, translates into a faster ability to respond to patients’ needs, delivering innovative treatments and fostering better access to healthcare.” and “The realization of this commitment, for which Sanofi stands very strongly, is possible because of the world-class healthcare infrastructure that the UAE offers,” he added. “We thank the Ministry of Health and Prevention for its leadership and unwavering partnership over the years.”

Marketing Strategies of Pharmaceutical Companies in the UAE

When it comes to analyzing the market strategies the U.A.E. pharmaceutical market is the second-largest in the Gulf Cooperation Council (GCC) after Saudi Arabia. The U.A.E. imports pharmaceutical products from 72 countries and 10 countries account for approximately 80 percent of the entire supply:  United Kingdom, Switzerland, Germany, Belgium, USA, France, Spain, Italy, and Australia.  In January 2017, the U.A.E.’s Ministry of Health (MoH) announced plans to increase the number of pharmaceutical manufacturing facilities to 30 by 2020 – up from 16 in 2017. Leading multinationals include Pfizer, Novartis, GlaxoSmithKline (GSK), Bayer, AstraZeneca, Merck, Abbvie, Eli Lily, BMS, and Amgen and now Sanofi.

An analysis of the health status of the United Arab Emirates

The United Arab Emirates (UAE) is a rapidly developing country composed of a multinational population with varying educational backgrounds, religious beliefs, and cultural practices, which face a challenge for population-based public health strategies.  A number of public health issues significantly contribute to the mortality rate in the UAE. so to overcome this headache a lot of pharmaceutical companies are trying to set up healthcare business in the country from all over the world.million and million people are getting benefited by their attempts. not only just the people but also the economic strategies are also developing by increasing the GDP of the country.

Over the past few decades, a  large number of factories have made which helped to increase employment all over the country. Now a tremendous pharmaceutical company Sanofi is all set to open the logistics hub in Dubai is a magnificent opportunity for the country.

Conclusion

The major public health challenges posed by certain lifestyle, occupational, and environmental factors associated with the development of chronic disease are not isolated to the UAE; rather, they form part of a global health problem, which requires international collaboration and action.  A major pharmaceutical company is opening up in the UAE so this is a huge step to improvise the healthcare facilities in the UAE. Contact us to get more opportunities to set up business firms all over the country.